Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Yuan ZengWenli RuanJiaxi HeJianrong ZhangWenhua LiangYaoqi ChenQihua HeJianxing He

Published in: PloS one (2016)

Adoptive immunotherapy has the potential to improve overall survival in postoperative NSCLC. The findings suggest this is a valid treatment option for these patients. Further randomized clinical trials are urgently needed.

Keyphrases

end stage renal disease
cell therapy
patients undergoing
ejection fraction
small cell lung cancer
newly diagnosed
chronic kidney disease
peritoneal dialysis
clinical trial
patient reported outcomes
risk assessment
free survival
combination therapy
replacement therapy